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Di¡erential Regulation of Cyclooxygenase-2 Expression by
Phytosphingosine Derivatives, NAPS and TAPS, and its Role
in the NAPS or TAPS-Mediated Apoptosis
Hye Jung Kim,Weonhye Shin,1 Chang Seo Park, Hyung-Ok Kim, and Tae-Yoon Kim
Department of Dermato-Immunology,The Catholic University of Korea, Seoul, South Korea;Doosan Biotech,Yongin, South Korea
We investigated the e¡ect of novel phytosphingosine de-
rivatives, N-acetyl phytosphingosine (NAPS) and tetra-
acetyl phytosphingosine (TAPS), on induction of apop-
tosis in HaCaT cells in comparison with C2-ceramide.
NAPS/TAPS e¡ectively decreased cell viability in a
dose dependent manner mainly due to apoptosis. An
apoptosis expression array analysis showed that in the
TAPS treated cells 13 genes including COX-2 encoding
cyclooxygenase-2, the most induced byTAPS, were up-
regulated while 23 others down-regulated. Therefore,
we examined the mechanism underlying the altered ex-
pression of COX-2. Assays with inhibitors and antibo-
dies against proteins involved in signal transduction
demonstrated that NAPS andTAPS elevated COX-2 ex-
pression via tyrosine kinase, src, PI-3 kinase and PKC,
followed by ERK activation. However, P38 was not in-
volved in the NAPS-mediated COX-2 expression but in
the TAPS-mediated.We further demonstrated by FACS
analyses that NAPS- or TAPS-mediated apoptosis was
greatly increased in cells treated with celecoxib, a selec-
tive COX-2 inhibitor. Inhibition of the ERK pathway
apparently involved in the NAPS/TAPS-mediated
COX-2 expression enhanced the NAPS/TAPS-mediated
apoptosis, whereas inhibition of the P38 pathway did
not. These results suggest that expression of COX-2 in
the TAPS- or NAPS-treated cells may be increased to
counteract the e¡ect of those compounds on apoptosis.
Key words: NAPS/TAPS/COX-2/ERK/apoptosis. J Invest
Dermatol 121:1126 ^1134, 2003
S
phingolipids are found in all eukaryotic cells and
enriched in the plasma membranes, Golgi membranes,
and lysosomes (Merrill et al, 1997; Huwiler et al, 2000).
Sphingolipid metabolites such as ceramides and sphin-
gosines play important parts in regulating cellular activ-
ities, and have been implicated as putative second messengers in
the signaling pathways (Merrill et al, 1997). Ceramides regulate
cell di¡erentiation, cell cycle arrest, proliferation, and apoptosis
(Mathias et al, 1998; Perry and Hannun, 1998). Sphingosine also
induces apoptosis and growth inhibition in various cell types as
an intracellular signal mediator (Spiegel and Merrill, 1996).
Phytosphingosine (PS) is abundant in fungi and plants (Dick-
son, 1998) and is present in animals, including humans (Schurer
et al, 1991). PS is structurally similar to sphingosine and ceramide
with one major di¡erence: PS possesses a hydroxyl group at C-4
of the sphingoid long-chain base, whereas sphingosine and cera-
mide both contain a trans double bond between C-4 and C-5
(Lee et al, 2001). It has been reported that both PS and N-acetyl
phytosphingosine (NAPS) were involved in the heat stress re-
sponse of Saccharomyces cerevisiae (Jenkins et al, 1997; Wells et al,
1998), and induced cell death in Chinese hamster cells (Lee et al,
2001). Little is known, however, about the cellular functions of
the PS derivatives.
Cyclooxygenase (COX)-2 overexpression in cancer cells may
promote tumor growth by imparting resistance to apoptosis.
Consistent with this, a null COX-2 mutation in APCD716 knock-
out mice, which is a murine model of familial adenomatous poly-
posis, restored the apoptosis and reduced the size and the number
of colorectal adenomas (Oshima et al, 1996). The role of COX-2,
however, in the induction of apoptosis and in skin tumor
development is still controversial. Overexpression of the COX-2
protein has been reported to induce cell cycle arrest indepen-
dently of the prostaglandins, which leads to the induction of
apoptosis (Trifan et al, 1999). In addition, a speci¢c COX-2 inhi-
bitor, celecoxib induced apoptosis but its proapoptotic e¡ect was
independent of COX-2 inhibition in mouse embryo ¢broblasts,
which were derived from COX-2(þ /^) and COX-2(^/^) mice
(Williams et al, 2000). Moreover, observations relating to the
proapoptotic e¡ect of nonsteroidal anti-in£ammatory drugs has
resulted in contradictory conclusions in that the proapoptotic ac-
tivity of the COX inhibitors occurs via either COX-dependent
or COX-independent mechanisms (Rigas and Shi¡, 2000).
It was reported that ceramides induce apoptosis and enhance
COX-2 expression. C2-ceramide was shown to increase COX-2
expression through a signal transduction pathway mediated by
the extracellular signal-regulated kinase (ERK), c-Jun N-term-
inal kinase, and p38 mitogen-activated protein kinase (MAPK),
which belong to the MAPK family in human mammary
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epithelial cells (Subbaramaiah et al, 1998). The MAPK family con-
sists of a set of serine threonine protein kinases, which leads to
proto-oncogene expression (Cobb, 1999; Thomson et al, 1999;
Pages et al, 2000). The activated MAPK may translocate to the
nucleus, where they phosphorylate their target proteins (Coso
et al, 1995). Ceramides mediate their e¡ects by activating phospho-
protein phosphatases (Dobrowsky and Hannun, 1992) and serine/
threonine kinases (Liu et al, 1994) that may increase Raf activity
(Zhang et al, 1997), and by inhibiting phospholipase D (Gomez-
Munoz et al, 1994).
In this study, we examined the e¡ects of the novel PS deriva-
tives, NAPS and tetraacetyl phytosphingosine (TAPS), on the in-
duction of programmed cell death of an immortalized human
keratinocytes cell line HaCaT, and identi¢ed the genes of altered
expression in the TAPS-treated cells. TAPS remarkably increased
COX-2 expression at the mRNA level.The focus of this study was
therefore to examine (1) signaling pathways, by which novel PS
derivatives, NAPS and TAPS, turn on the expression of COX-2,
and (2) the role of COX-2 in NAPS- orTAPS-mediated apoptosis.
MATERIALS AND METHODS
Materials The PS derivatives, NAPS and TAPS, were provided from
Doosan Biotech (Yongin, Korea), and N-acetyl-D-erythrosphingosine
(C2-ceramide) was from Sigma (St Louis, Missouri). The identity of PS
derivatives was con¢rmed by nuclear magnetic resonance spectroscopy
and matrix-assisted laser desorption ionization-time of £ight mass
spectrometry. The purity of the NAPS or TAPS was greater than 98% by
high performance liquid chromatography (Lee et al, 2001) (Fig 1). NAPS
and TAPS in dimethyl sulfoxide were aliquoted in small amounts and
stored at ^201C until used. An In Situ Cell Death Detection Kit was
obtained from Boehringer Mannheim (Mannheim, Germany). The MTT
(3-(4,5-dimethylthiazol-2-yl) 2,5-diphenyl tetrazolium bromide) and all
other chemicals were purchased from Sigma. Celecoxib was kindly
provided by Pharmacia Biotech Inc. (San Francisco, California). [a-32P]
deoxycytidine triphosphate (3000 mCi per mmol) was purchased from
Amersham (Piscataway, New Jersey). Dulbecco’s modi¢ed Eagle medium
and fetal bovine serum were obtained from Gibco BRL (Rockville,
Maryland). Anti-COX-2 and anti-b-tubulin were purchased from Santa
Cruz Biotechnology (Santa Cruz, California), and anti-p-MEK1/2 and
p-p38 antibodies were obtained from Cell Signaling Technology (Beverly,
Massachusetts). PP1, U73122, and GF109203X were obtained from Biomol
(Plymouth Meeting, Pennsylvania). Genistein was purchased from Alexis
(San Diego, California), and SB203580, U0126, and PD98059 acquired
from Calbiochem (San Diego, California). All other chemicals, including
LY294002, were purchased from Sigma.
Cell culture The immortalized human keratinocyte cell line, HaCaT,
was kindly provided by Professor N. Fuseng (German Cancer Research,
Germany). Cells were maintained as monolayer cultures in Dulbecco’s
modi¢ed Eagle medium supplemented with 10% fetal bovine serum, 100
units per mL penicillin, and 100 mg streptomycin per mL at 371C in a
humidi¢ed atmosphere containing 5% CO2. The cells were then seeded
at a density of 1106 cells per 100 mm dishes. After 48 h, the cells were
washed with serum-free medium, replaced with media without fetal
bovine serum for 12 h prior to treatment with PS derivatives.
Assessment of cell viability (MTT assay) The cell viability was
determined colorimetrically using the MTT reagent. The MTT assay was
performed as previously described (Wilson and Spier, 1987).
TUNEL (terminal deoxynucleotidyl transferase-mediated deoxy-
uridine triphosphate nick end-labeling) assay TUNEL assay of the
nucleosomal DNA fragments using a commercially available ‘‘In Situ Cell
Death Detection Kit’’ (Boehringer Mannheim) was employed according to
the manufacturer’s protocol. This method was used to ensure the safe
discrimination between apoptosis and necrosis.
Treatment of cells with inhibitors Cells were pretreated with 20 mM
LY294002 (an inhibitor of phosphatidylinositol (PI3)-kinase), 40 mM
PD98059 (a selective ERK inhibitor), 5 mM SB203580 (a p38 inhibitor),
10 mM U0126 (a MEK inhibitor), 10 mM PP1 (a src family speci¢c
inhibitor; Klint et al, 1999), 100 mM genistein (a tyrosine kinase inhibitor),
or 5 mMGF109203X (a protein kinase C (PKC) inhibitor;Wolfe et al, 1996)
for 1 h in serum-free medium, and then exposed to 30 mMNAPS orTAPS
for the indicated time points. For £uorescence-activated cell sorter (FACS)
analysis, cells were also pretreated with 10 mM celecoxib (a speci¢c COX-2
inhibitor) for 1 h, before treatment with 30 mM of either NAPS or TAPS.
Immunochemistry analysis Cells were harvested and lyzed with a
RIPA bu¡er containing 0.5% sodium dodecyl sulfate, 1% nonidet P40,
1% sodium deoxycholate, 150 mM NaCl, 50 mM Tris^Cl (pH 7.5), and
protease inhibitors. The protein concentration of each sample was
determined using a BCA protein assay kit (Pierce, Rockford, Illinois).
Twenty micrograms of the total protein for COX-2 detection were
electrophoresed on 8% polyacrylamide gels and 80 mg for phospho-
MAPK detection on 12% polyacrylamide gels. The proteins were transfer-
red on to the nitrocellulose membranes by a semidry electrophoretic
transfer process on a Bio-RadTransBlot SD (Bio-Rad Laboratories, Hercules,
CA) apparatus at 15 V for 60^75 min. The nitrocellulose membranes were
blocked overnight at 41C in 5% bovine serum albumin. The membranes
were incubated with the primary antibodies in TBST containing 5% bovine
serum albumin, for 2 h.This was followed by incubation with the secondary
antibodies at room temperature for 1 h. Anti-goat IgG for COX-2 or anti-
rabbit IgG for p-MEK1/2 or p-p38 was used as a secondary antibody (1:5000
dilution in TBST containing 1% bovine serum albumin). The signals were
detected using ECL (Amersham).
Flow cytometric analysis FACS analysis was performed using a slight
modi¢cation of the method described by Telford et al (1994). Brie£y, the
cells were pelleted at 350 g and washed once with 10 mL of ice-cold
phosphate-bu¡ered saline. The pellets were resuspended in 70% ethanol,
and then kept on ice for 60 min. Cells were then permeabilized in a
reagent consisting of 0.5% Triton X-100, 230 mg per mL RNaseA and
propidium iodide to 50 mg per mL in phosphate-bu¡ered saline. The
samples were kept at 371C for 30 min followed by £ow cytometry
analysis (Becton Dickinson FACScan Becton Dickinson, Franklin Lakes,
NJ), and the apoptotic populations (sub-G1 phase) were analyzed by the
CellQuest program (BD Bioscience Franklin Lakes, NJ).
Apoptosis microarray assay An aliquot of 2 mg of total RNAwas used
in the microarray analyses, which were performed according to the Human
Apoptosis Expression Array kit manual (R&D, Minneapolis, Minnesota).
Total RNAwas reverse-transcribed with avian myeloblastosis virus reverse
transcriptase using apoptosis-speci¢c primers and labeled with [a32p]
cytidine triphosphate. Labeled cDNAwere puri¢ed using Sephadex G-25
spin column and hybridized with the array overnight at 651C according to
the manufacturer (R&D). Reagents included in the array kit were used for
all hybridization.Wash solution I (0.5 SSPE, 1% (w/v) (sodium dodecyl
sulfate) and wash solution II (0.1SSPE, 1% (w/v) (sodium dodecyl
sulfate) were used for washing steps. Membranes were exposed on Fuji RX
X-ray ¢lm.
Analysis of the array results Gene expression data were normalized
against the housekeeping gene such as b2M, b-actin, cyclophilin A, HLA-
A 0201 heavy chain, hypoxanthine^guanine phosphoribosyltransferase, L19,
transferrin R, and a-tubulin which were shown at a constant level in all
arrays. The Genesight 3.2 program from Biodiscovery (Biodiscovery Inc.
Microray Systems, Marina del Ray, CA) was used to analyze the data, and
all gene values were normalized against the housekeeping gene.
Data analysis Scanning densitometry was performed using an Image
Master VDS (Pharmacia Biotech Inc.). The one-way ANOVA procedure was
used to assess the signi¢cant di¡erences among the treatment groups. For
each signi¢cant e¡ect of treatment, the Newman^Keuls test was used for
signi¢cance set at po0.05 or po0.01.
Figure1. Structure of NAPS and TAPS.
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RESULTS
E¡ects of PS derivatives on the cell viability of the human
keratinocytes HaCaT in a concentration-dependent manner
The e¡ects of the PS derivatives, NAPS and TAPS, and
C2-ceramide on the viability of HaCaT cells were examined
using the MTT assay. After incubating the HaCaT cells in the
presence of 1 to 30 mM of each compound for 24 h, the cell
viability was reduced as the concentration increased (Fig 2).
Considering the ED50 value, NAPS and TAPS induced the
death of keratinocyte cells as e¡ective as C2-ceramide in
cytotoxicity, but they exerted strong cytotoxicity at 30 mM
(viability 20%), compared with C2-ceramide (viability 40%). It
was reported that the hydroxyl group at C4- of the sphingosine
long-chain base is critical for its anti-proliferative activity and the
N-acetyl group is also important for cytotoxicity (Lee et al, 2001).
These results suggest that PS as well as sphingosine and
C2-ceramide trigger HaCaT cell death.
PS derivatives induce apoptosis in a concentration-
dependent manner A TUNEL assay was performed in order
to determine if the cytotoxicity of the PS derivatives was related
to apoptosis (Fig 3). The results show that the TUNEL-positive
cells were detected in the NAPS-,TAPS-, or C2-ceramide-treated
cells at 10 mM and 30 mM, respectively. The percentage of
TUNEL-positive cells for TAPS, NAPS, or C2-ceramide was
29%, 35%, or 17% at 30 mM, respectively, suggesting that TAPS
or NAPS induced apoptosis more e¡ectively than C2-ceramide.
Altered expression of genes encoding apoptosis-related
proteins in TAPS-treated cells To ¢gure out factors res-
ponsible for the apoptosis mediated by a PS derivative, TAPS,
we performed apoptosis expression array comprising 198 genes
involved in apoptosis. Total mRNA was isolated from the
TAPS-treated cells and the control cells, respectively. We
identi¢ed genes, whose expression altered by at least 2-fold in
the TAPS-treated cells compared with the control cells. The
genes with altered expression in the TAPS-treated HaCaT cells
were classi¢ed based on their cellular function and listed in
Tables I and II. Among 198 genes on the array membrane, 13
genes were increased in TAPS-treated cells compared with
control cells, whereas 23 genes were repressed (Tables I and II).
Five genes were cell cycle regulator genes: p21, p53, cyclin A2,
CDK2, and RdAp48. It is interesting to note that p21 and p53
were di¡erentially expressed and that p21 was induced, whereas
p53 was reduced. Apoptosis suppressor survivin and IAP-1 were
downregulated by TAPS. Interestingly, apoptosis array analysis
showed that expression of COX-2, which is known to be
involved in the proliferation blocking apoptosis in cancer cells,
dramatically increased (approximately 16.6-fold) withTAPS (30 mM)
treatment.
NAPS and TAPS induce COX-2 protein more than
C2-ceramide In this study, our focus was to examine the
induction mechanism of COX-2 protein by the PS derivatives,
NAPS and TAPS, and compared them with PS and C2-
ceramide. The human keratinocyte cell line, HaCaT, was treated
with 30 mM of PS, NAPS, TAPS, or C2-ceramide for 24 h.
Figure 3. PS derivatives induced apoptosis in
a concentration-dependent manner. HaCaT
cells were incubated with NAPS, TAPS, and C2-
ceramide at a concentration of 10 and 30 mM for
24 h. The induction of apoptosis by NAPS,TAPS,
and C2-ceramide was determined by a TUNEL
assay as described inMaterials and Methods. The ex-
periments were performed three times.
Figure 2. PS derivatives induce cell
toxicity in a concentration-dependent
manner. At a concentration of 1 to 30 mM,
the NAPS-,TAPS-, and C2-ceramide-trea-
ted cells for 24 h exhibited cytotoxicity in
a concentration-dependent manner, as
con¢rmed by the MTT assay. The results
are shown as a mean7SEM of three inde-
pendent experiments.
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Western blot analysis showed that the COX-2 protein level
was signi¢cantly higher in the NAPS- or TAPS-treated cells
(approximately 15- and 22-fold, respectively) than in the control
cells (Fig 4A). In contrast, the C2-ceramide- and PS-treated cells
showed a relatively small increase in the COX-2 protein level
compared with the control cells. The induction of COX-2
protein was not apparent at a concentration of between 1 and 10
mM, but 30 mM of NAPS, TAPS, or C2-ceramide dramatically
increased COX-2 induction (Fig 4B). In addition, this
concentration induced apoptosis e⁄caciously in the HaCaT cells
(Fig 3). Samples were taken at the indicated time points in order
to monitor COX-2 production with respect to time after
treatment. Production of COX-2 at 30 mM of TAPS became
apparent 4 h after treatment, its level reached a maximum at 8 h
and decreased thereafter (Fig 4C). Unlike TAPS, NAPS-induced
COX-2 expression increased steadily to a maximum 16 h after
treatment and this level was sustained until 24 h. C2-ceramide
appeared to increase maximally the COX-2 protein level at 8 h,
but COX-2 induction by C2-ceramide was weak when compared
with NAPS or TAPS.
ERK and p38 contribute to the induction of COX-2 by
TAPS, but p38 is not involved in the NAPS-induced
COX-2 induction It has been reported that the C2-ceramide-
induced COX-2 promoter activity was inhibited by the
dominant negative mutant of ERK 2 and p38 (Chen et al, 2001).
In order to determine if ERK or p38 is also involved in the
signaling pathways for the COX-2 induction by the novel PS
derivatives NAPS or TAPS in HaCaT cells, the NAPS- or TAPS-
induced COX-2 protein level was examined after suppressing
either p38 or ERK using their inhibitors. As shown in Fig
5(A,B), blocking ERKwith a selective ERK inhibitor, PD98059
(40 mM), almost completely abrogated theTAPS-induced COX-2
increase at 8 h, whereas it inhibited the NAPS-induced COX-2
increase to a lesser degree. The induction of the COX-2 protein
by TAPS was also signi¢cantly inhibited by pretreatment with
the p38 inhibitor, SB203580 (5 mM), but no alteration was
observed in the COX-2 production induced by NAPS despite
the treatment with SB203580, rather it increased slightly.
Furthermore, 10 mM U0126, a MEK inhibitor, e¡ectively
inhibited the TAPS-induced COX-2 protein, but only inhibited
the NAPS-induced COX-2 protein level to a lesser degree, the
extent of which was comparable with that inhibited by
PD98059, an ERK inhibitor. These results suggest that TAPS
increases COX-2 expression via the ERK and p38 pathway.
ERK, however, is a greater contributor than p38, and NAPS
may not act via p38 pathway.
NAPS andTAPS also increase the COX-2 expression through
PI3-kinase It has been reported that ceramide stimulates
¢broblast division by activating tyrosine phosphorylation,
Ras, and PI3-kinase) (Hanna et al, 1999). Therefore, this study
examined whether or not the inhibition of PI3-kinase with
LY294002 blocks the COX-2 induction by both NAPS and
TAPS. Immunoblot analysis showed that a pretreatment with 20
mM LY294002 for 1 h almost completely prevented the increase
in COX-2 protein levels by NAPS or TAPS. These results show
that both NAPS and TAPS increase COX-2 expression through
PI3-kinase (Fig 6A,B).
Tyrosine kinase, src, and PKC are di¡erentially involved in
the induction of COX-2 by NAPS or TAPS Figure 6
shows that PI3-kinase is involved in the NAPS- or TAPS-
mediated COX-2 induction. One of the mechanisms by which
ceramide regulates gene expression is through activating the
PKC signal transduction pathway (Subbaramaiah et al, 1998).
COX-2 is a target of activated PKC (Subbaramaiah et al, 1998).
Tyrosine kinase phosphorylates src and PI3-kinase, which is
followed by activation of phospholipase C or PKC. Therefore,
genistein (100 mM), which is a tyrosine kinase inhibitor, was
Table I. Upregulated apoptosis related genes in TAPS-treated
cells
Protein/gene Array coordinates Accession no. Fold
Apoptosis related
COX-2 H2 M90100 16.56
Bcl-2 related
Bcl-x G7 U72398 2.09
Cytokine
IL-1b H12 M15330 9.53
IFN-g R2 C12 U05875 2.85
erbB3 I11 M29366 2.13
IL-4Ra C13 X52425 2.03
Cell cycle regulator
p21 K9 U03106 6.98
Signal transduction factor
DRAK2 N16 NM_004226 3.62
Bcl-10 H16 NM_003921 3.28
TANK B18 NM_004180 2.64
RIP N17 U50062 2.18
DRAK1 M16 NM_004760 2.23
Tumor necrosis factor superfamily
TRAIL R2 F22 AF012535 2.57
After HaCaT cell was treated with TAPS at a concentration of 30 mM for 24 h,
total RNAwas extracted. An aliquot of 2 mg of total RNAwas used in the mi-
croarray analysis, performed according to the Human Apoptosis Expression Array
kit manual (R&D). The Genesight 3.2 program from Biodiscovery was used to
analyze the data, and all gene values were normalized against the housekeeping
gene.
Table II. Downregulated apoptosis related genes in
TAPS-treated cells
Protein/gene Array coordinates Accession number Fold
Apoptosis related
FLASH O2 AF154415 0.40
DFF40 E2 NM_004101 0.79
Apoptosis suppressor
Survivin C6 U75285 0.38
IAP-1 N5 U45878 0.40
Bcl-2 related
Bax-a N6 L22473 0.66
Bag-1 L6 NM_004323 0.73
Caspase related
PARP I8 M18112 0.57
Caspase-8 E8 NM_001228 0.81
Caspase-1 M7 M87507 0.77
Cell cycle regulator
Cyclin A2 F9 NM_001237 0.46
CDK2 D9 X61622 0.50
RdAp48 D10 X74262 0.74
p53 M9 M14695 0.81
Cytokine
ErbB2 H11 NM_004448 0.60
Dtk G11 U05682 0.57
Neutrophic group
TrkB M15 U12140 0.67
Signal transduction factor
NIK H17 NM_003954 0.20
TRIP H18 U77845 0.31
TRAF2 E18 U12597 0.72
ALG4 F16 D80007 0.54
14-3-3 protein E16 U28964 0.77
Tumor necrosis factor superfamily
TRAIL D22 U57059 0.33
Fas N20 M67454 0.62
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used to examine if tyrosine kinase is involved upstream of
PI3-kinase in NAPS- or TAPS-induced COX-2 induction.
Immunoblot analysis showed that the genistein pretreatment
reduced the TAPS-induced COX-2 protein levels indicating
involvement of a tyrosine kinase (Fig 7B).We also examined if
src is involved in the TAPS-induced COX-2 protein induction.
The COX-2 protein induction by TAPS was completely
prevented by pretreatment with 10 mM PP1, a src inhibitor (Fig
7B). In addition, GF109203X, a PKC inhibitor, inhibited the
induction of the COX-2 protein by TAPS (Fig 7B) at 5 mM.
The induction of the COX-2 protein by NAPS, however, was
not blocked by pretreatment with genistein, PP1, or GF109203X
(Fig 7A). These results suggest that NAPS and TAPS
di¡erentially regulate COX-2 expression. TAPS might regulate
COX-2 expression through autophosphorylation of tyrosine
kinase, which is followed by the activation of src and PI3-
kinase, and ¢nally by the activation of the PKC and/or ERK
pathway. The COX-2 expression by NAPS might be also
mediated through the PI3-kinase and ERK pathway. Upstream
signal molecules that regulate the COX-2 expression induced by
NAPS, however, needs to be further studied.
Figure 4. NAPS and TAPS induce the pro-
duction of COX-2 protein more than C2-
ceramide. (A) Immunoblot analysis of the
COX-2 protein and the relative COX-2 protein
level. Con£uent HaCaT cells were treated with
PS, NAPS, TAPS, or C2-ceramide (30 mM) and
the total cell lysate was extracted from the cells
after 24 h incubation. Each lane was loaded with
20 mg of the cell lysates. The detailed procedure is
described in Materials and Methods. The relative
COX-2 protein levels were normalized by scan-
ning densitometry. The data are shown as a
mean7SEM of three independent experiments.
One-way analysis of variance was used for the
comparisons of the multiple group means fol-
lowed by Newman^Keuls test (signi¢cance com-
pared with control, po0.05 or po0.01)
(control level¼1). (B) The representative immu-
noblot shows that HaCaT cells treated with
NAPS, TAPS, or C2-ceramide for 24 h showed a
marked increase at a concentration of 30 mM (C)
Immunoblot analysis for COX-2 protein was per-
formed in NAPS-, TAPS-, or C2-ceramide-trea-
ted HaCaT cells. The total cell lysate was
extracted from the cells at the indicated times.
The data were con¢rmed by two repeated
experiments.
Figure 5. ERK and p38 contribute to the expression of COX-2
by TAPS, but p38 is not involved in the NAPS-induced COX-2
expression. Induction of the COX-2 protein by NAPS (A) and TAPS
(B). The level of the COX-2 protein was assessed by immunoblot, and the
relative COX-2 protein levels were plotted after scanning densitometry.
Expression of the COX-2 protein was measured from NAPS-treated cells
for 16 h or TAPS-treated cells (30 mM) for 8 h after 1 h pretreatment with
ERK inhibitor PD98059 (40 mM), p38 inhibitor SB203580 (5 mM), and
MEK inhibitor U0126 (10 mM). Data represent the mean7SEM of three
separate experiments. One-way analysis of variance was used for the com-
parisons of the multiple group means followed by Newman^Keuls test
(signi¢cance compared with the control, po0.01; signi¢cant compared
with NAPS or TAPS, wwpo0.01) (control level¼1).
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Treatment with various kinase inhibitors indirectly showed
that upregulation of COX-2 byTAPS or NAPS occurs through
the ERK pathway or PI3^PKC pathway. We further examined
whether TAPS indeed facilitates phosphorylation of MEK or
p38, moreover, if these inhibitors are blocking their target
pathways as predicted. Results showed that phosphorylation
of MEK was detected at early time (E5 min) point after
TAPS treatment and sustained until 12 h (Fig 8). Phospho-p38
was also increased in TAPS-treated cells. TAPS-induced
phosphorylation of MEK or p38, however, was inhibited by the
preincubation of cells with PD98059 or SB203580. These results
suggest that the ERK pathway is mainly involved in COX-2
induction by TAPS. Regarding the signaling pathway related to
the COX-2 induction of C2-ceramide compared with that of
NAPS or TAPS appeared to adopt a signal pathway similar to
that of TAPS (Fig 9).
Inhibition of COX-2 function enhances signi¢cantly NAPS-
or TAPS-mediated apoptosis NAPS- and TAPS-induced
apoptosis was previously shown byTUNEL assay. The e¡ects of
the COX-2 inhibition by a selective COX-2 inhibitor, celecoxib,
on NAPS- or TAPS-induced apoptosis were examined in order
to test if induction of COX-2 is part of a protective mechanism
to compensate for NAPS- or TAPS-induced apoptosis.We used
30 mM of NAPS or TAPS, at which concentration COX-2
protein production as well as the sub-G1 population was
remarkably elevated. Twenty-four hours after HaCaT cells were
exposed to either NAPS or TAPS with or without celecoxib
(10 mM) cells were collected and treated with propidium iodide
for the FACScan to determine the sub-G1 DNA content. FACS
analysis showed that the cells exposed to either NAPS or TAPS
and celecoxib resulted in a remarkable increase in the cell death
rate (Fig 10B). Co-treatment with NAPS or TAPS and celecoxib
increased the sub-G1 percentage from 26.1 to 56.57% or from 33.4
to 60.47% when compared with the treatment with NAPS or
TAPS alone. These results demonstrate that COX-2 protects the
cells from NAPS- or TAPS-induced apoptosis, and that an
impairment of COX-2 function leads to a pronounced increase
in apoptosis.
The sub-G1 population was monitored by FACS analysis after
adding 40 mM PD98059 to the cells treated with NAPS or TAPS
(Fig 10B) in order to address whether or not the ERK signaling
pathway involved in the COX-2 expression by NAPS or TAPS
plays an important part in protecting cells from NAPS- or
TAPS- induced apoptosis. It should noted that the cells cotreated
with PD98059 increased the sub-G1 population by up to 44.60%
and 53.05%, when it was combined with both NAPS orTAPS. In
contrast, p38 inhibition using SB203580 failed to increase the
sub-G1 population by TAPS, and even blocked the sub-G1
population induced by NAPS from 26.1 to 20.19%. This result
corresponds to the fact that p38 inhibition slightly increased the
COX-2 expression level induced by NAPS. These results show
that the ERK signaling pathway protects cells from the
Figure 6. NAPS or TAPS also increase the expression of COX-2
through PI3-kinase. HaCaTcells were treated with NAPS (A) and TAPS
(B) after preincubation for 1 h with PI3-kinase inhibitor 20 mM LY294002
16 h or 8 h later, cell lysate was extracted from the cells and immunoblot
analysis was performed as described in Fig 5. The data were con¢rmed by
three independent experiments.
Figure 7. Tyrosine kinase, src, and PKC are involved in the NAPS-
or TAPS-mediated COX-2 induction. The cell lysate was extracted
from the cells treated with NAPS (A) for 16 h or TAPS (B) for 8 h after
preincubation for 1 h with the tyrosine inhibitor, genistein (GT) 100 mM,
the src inhibitor, PP1 (10 mM), and the PKC inhibitor, GF109203X (5 mM),
and immunoblot analysis was performed, as described in Fig 5. The data
were con¢rmed by two repeated experiments.
Figure 8. TAPS phosphorylates MAPK.
The cell lysate was extracted from the cells
treated with TAPS at indicative times and
then immunoblot analysis was performed
using anti-p-MEK1/2, anti-p-p38, anti-
MEK1/2, and anti-p38 antibodies. To
determine the speci¢city of the MAPK in-
hibitors, HaCaT cells were harvested from
the cells treated with TAPS for 8 h after
preincubation for 1 h with ERK inhibitor
PD98059 and p38 inhibitor SB203580.
Each lane was loaded with 80 mg of the
cell lysates. The data were con¢rmed by
three times repeated experiments.
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apoptosis caused by NAPS orTAPS by being involved in the COX-
2 expression. Furthermore, these results provide a notion that p38
might negatively regulate the COX-2 expression by NAPS.
DISCUSSION
This study showed that the PS derivatives, NAPS and TAPS, in-
duced apoptosis more e¡ectively than C2-ceramide. It was found
through expression array analysis that COX-2 was the most
strongly induced gene among the genes upregulated byTAPS at
the mRNA level.
It has been reported that a variety of stimuli, including tumor
necrosis factor-a, interleukin-1b, phorbol esters, g-interferon, and
ultraviolet light stimulate the hydrolysis of sphingomyelin by
sphingomyelinase (Smase), which results in the formation of cer-
amide, and induces COX-2 (Okazaki et al, 1990; Herschman,
1996; Spiegel et al, 1996; Huang et al, 1997; Sbrissa et al, 1997; Buck-
man et al, 1998). Therefore, it is possible that these agonists induce
COX-2 at least in part, via ceramide signaling. It is known that
ceramide induces apoptosis, whereas COX-2 overexpression inhi-
bits apoptosis (Tsujii and DuBois, 1995; Verheij et al, 1996). Sub-
baramaiah et al (1998) proposed that the proapoptotic e¡ects of
ceramide may be counteracted, in part, by its ability to upregu-
late COX-2. A detailed mechanism demonstrating the relation
between the induction of apoptosis and COX-2 expression by
ceramide, however, has not been studied. The mechanism by
which novel PS derivatives, NAPS and TAPS, induce COX-2
expression, and its role in the NAPS- or TAPS-mediated apopto-
sis in human keratinocytes are unclear. Therefore, this study
examined the induction mechanism of the COX-2 gene by
NAPS and TAPS, and the role of COX-2 in inducing apoptosis.
Ceramide signaling can be mediated by PKC (Sbrissa et al,
1997). PKC can activate Raf-1, which in turn, regulates the
MAPK activity (Reunanen et al, 1998). Ceramide was previously
Figure 9. C2-ceramide induces COX-2 protein through tyrosine ki-
nase, PI3-kinase, and ERK pathway.The cells were treated with 30 mM
C2-ceramide after preincubation for 1 h with the PI3-kinase inhibitor,
LY294002, the ERK inhibitor, PD98059, the p38 inhibitor, SB203580, the
MEK inhibitor, U0126, the tyrosine inhibitor, genistein (GT), the src in-
hibitor, PP1 and the PKC inhibitor, GF109203X. Eight hours later, the cell
lysate was extracted from the cells and immunoblot analysis was performed
as described in Fig 5. The data were con¢rmed by two independent
experiments.
Figure10. Inhibition of COX-2 induc-
tion enhanced NAPS- or TAPS-
mediated apoptosis. (A) The cells were
exposed to celecoxib, NAPS, or TAPS at a
concentration of 10 or 30 mM for 24 h. Cell
were then harvested for FACS analysis. (B)
The cells were pretreated with 40 mM
PD98059 and 5 mM SB203580 for 1 h. After
24 h coincubation with either NAPS or
TAPS at a concentration of 30 mM, the cells
were collected for FACS analysis. The M
cell population represents the apoptotic
cells from each sample.
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shown to induce the p38, c-Jun N-terminal kinase, and ERK/
MAPK activities (Reunanen et al, 1998). COX-2 expression can
be a¡ected by changes in the MAPK activity (Xie and Hersch-
man, 1995, 1996; Guan et al, 1998). Several lines of evidence suggest
that the COX-2 induction by ceramide occurs via ERK, c-Jun
N-terminal kinase, and p38 MAPK activation (Xie and Hersch-
man, 1995, 1996; Guan et al, 1998; Subbaramaiah et al, 1998). This
study showed that the induction of COX-2 byTAPS was blocked
by GF109203X, a potent and selective PKC inhibitor. In addition,
it was found that MEK, ERK, and p38 are important for mediat-
ing the induction of COX-2 byTAPS. Moreover, PI3-kinase was
also involved in the COX-2 induction by either NAPS or TAPS;
however, we cannot rule out the possibility that the hydrocarbon
chains of PS may facilitate a hydrophobic interaction with their
cellular targets such as fatty acids, thereby indirectly exerting
these e¡ects.
To elucidate further the mechanism by which TAPS signaling
induces COX-2 expression, tyrosine kinase and src were also ex-
amined to determine if they are involved in COX-2 expression.
The results showed that TAPS increased the COX-2 protein level
by activating tyrosine kinase and src. This is consistent with pre-
vious reports showing that ceramide formation in ¢broblasts sti-
mulates the tyrosine kinase activity (Hanna et al, 1999), such as
pp60c^src (Su et al, 1999), resulting in Ras-GTP formation (Hanna
et al, 1999). Treating Rat2 ¢broblasts with ceramide caused
PI3-kinase to interact physically with Ras-GTP (Hanna et al,
1999) and the phosphorylated FAK (Hanna et al, 2001), resulting
in the synergistic activation of PI3-kinase (Rodriguez-Viciana
et al, 1996).
The regulation mechanism of COX-2 induction by NAPS,
however, appeared to di¡er from that induced by TAPS. NAPS
increased the COX-2 levels through the MEK and ERK path-
ways, but not through the p38 pathways. In addition, tyrosine
kinase, src, and PKC appeared unlikely to be related to the
COX-2 expression by NAPS. NAPS is di¡erent from TAPS in
having one N-acetyl group, whereas TAPS has a tetraacetyl
group. Lee et al (2001) reported that NAPS (also called C2-phyto-
ceramide in that study) showed a much stronger cytotoxic e¡ect
than C2-ceramide, suggesting that the hydroxyl group at C-4
of the sphingoid long-chain base is crucial for its cytotoxicity.
In addition, the size of the N-acyl group is also important
for the cytotoxicity. Therefore, the di¡erence in physiologic e¡ect
of NAPS and TAPS may be due to the substituent of the
sphingoid long chain base. We need to investigate further the
upstream signaling molecules involved in the COX-2 expression
by NAPS.
It is known that COX-2 overexpression appears to play an
important part in carcinogenesis (Wol¡ et al, 1998; Zimmermann
et al, 1999). Recent in vivo studies have shown that COX-2 is also
expressed in normal human skin as well as in various kinds of
tumor cells (Leong et al, 1996; Muller-Decker et al, 1999). Leong
et al (1996), however, revealed that COX-2 immunostaining
increased in the more di¡erentiated suprabasal keratinocytes sug-
gesting that COX-2 expression occurred as part of normal kera-
tinocyte di¡erentiation. It is possible to propose that the COX-2
overexpression by NAPS and TAPS may be to counteract the
increase in the apoptosis rather than to be somehow related to
development of the keratinocyte malignancy.
This study provides some information on the mechanism by
which novel PS derivatives, TAPS and NAPS, induce COX-2
expression, and demonstrate that COX-2 expression is related to
counteracting apoptosis by NAPS or TAPS in human keratino-
cyte HaCaT cells.
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